| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
|
Agrawal, Himanshu
|
|
|
17 |
1 |
p. 94-112
|
artikel
|
| 2 |
Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility
|
Golchin, Ali
|
|
|
17 |
1 |
p. 56-62
|
artikel
|
| 3 |
COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy
|
Verma, Yogesh Kumar
|
|
|
17 |
1 |
p. 113-131
|
artikel
|
| 4 |
Dimethyl Fumarate Can Enhance the Potential Therapeutic Effects of Epidermal Neural Crest Stem Cells in COVID-19 Patients
|
Safari, Anahid
|
|
|
17 |
1 |
p. 300-301
|
artikel
|
| 5 |
Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?
|
Bagheri, Hesam Saghaei
|
|
|
17 |
1 |
p. 214-230
|
artikel
|
| 6 |
Epidermal Neural Crest Stem Cells as a Perspective for COVID-19 Treatment
|
Salehi, Mohammad Saied
|
|
|
17 |
1 |
p. 291-292
|
artikel
|
| 7 |
Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics
|
Park, You Jeong
|
|
|
17 |
1 |
p. 9-32
|
artikel
|
| 8 |
Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein
|
Ropa, James
|
|
|
17 |
1 |
p. 253-265
|
artikel
|
| 9 |
Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible?
|
Virant-Klun, Irma
|
|
|
17 |
1 |
p. 278-284
|
artikel
|
| 10 |
Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage
|
Bose, Bipasha
|
|
|
17 |
1 |
p. 293-295
|
artikel
|
| 11 |
Is COVID-19 a New Hematologic Disease?
|
Debuc, Benjamin
|
|
|
17 |
1 |
p. 4-8
|
artikel
|
| 12 |
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19
|
Pinky,
|
|
|
17 |
1 |
p. 33-43
|
artikel
|
| 13 |
Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
|
Rocha, José Lucas Martins
|
|
|
17 |
1 |
p. 71-93
|
artikel
|
| 14 |
Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19
|
Desai, Drashti
|
|
|
17 |
1 |
p. 231-240
|
artikel
|
| 15 |
Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension
|
Saha, Sarama
|
|
|
17 |
1 |
p. 132-143
|
artikel
|
| 16 |
‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients
|
Raza, Syed Shadab
|
|
|
17 |
1 |
p. 153-162
|
artikel
|
| 17 |
Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs
|
Jamshidi, Elham
|
|
|
17 |
1 |
p. 176-192
|
artikel
|
| 18 |
P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo‐inflammation
|
Lintzmaier Petiz, Lyvia
|
|
|
17 |
1 |
p. 241-252
|
artikel
|
| 19 |
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises
|
Basiri, Arefeh
|
|
|
17 |
1 |
p. 163-175
|
artikel
|
| 20 |
Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19
|
Khavinson, V. Kh.
|
|
|
17 |
1 |
p. 285-290
|
artikel
|
| 21 |
Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19
|
Majolo, Fernanda
|
|
|
17 |
1 |
p. 44-55
|
artikel
|
| 22 |
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
|
Ratajczak, Mariusz Z.
|
|
|
17 |
1 |
p. 266-277
|
artikel
|
| 23 |
Stem Cells as Potential Therapeutics and Targets for Infection by COVID19 – Special Issue on COVID19 in Stem Cell Reviews and Reports
|
Ratajczak, Mariusz Z.
|
|
|
17 |
1 |
p. 1-3
|
artikel
|
| 24 |
Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients
|
Esquivel, Diana
|
|
|
17 |
1 |
p. 144-152
|
artikel
|
| 25 |
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
|
Basiri, Arefeh
|
|
|
17 |
1 |
p. 193-213
|
artikel
|
| 26 |
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
|
Berishvili, Ekaterine
|
|
|
17 |
1 |
p. 63-70
|
artikel
|
| 27 |
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient
|
Szwebel, Tali-Anne
|
|
|
17 |
1 |
p. 296-299
|
artikel
|
Tijdschrift beschrijving